Medical School for International Health in collaboration with Columbia University Medical Center


Head: Carmi Margolis, M.D.,M.A.

Phone: 08-6479909/8
E-mail: mcarmi@bgumail.bgu.ac.il
More information / Department Site

Staff Members
Michael Alkan
 
HIV, TBC, Hospital infections control
Gabriel Amitai
David Israel Andrews
David Arnstein
Lone Avnon
 
pulmonery medicine
Sivan Bagola
Orit Bar Yshay
Iddo Bar-Yishay
Haggai Bar-Yoseph
Avner Belkin
Michal Benkler
Gadi Benshalom
Amir Bieber
Yael Bohbut
Ron Charach
Lynette Conroy
Sharon Dagan
Bracha Dagan
Michael Diamond
Shlomit Frida
Raya Gal
Ronen Ghinea
Shimon Glick
Jacob Gopas
 
Biology and prognostic aspects of Hodgkin's Lymphoma Drug resistance in malignant melanoma Anticancer properties of medicinal plants
Evgenia Gorevich
Ya'akov Henkin
 
Preventive Cardiology, Lipoproteins, coronary Risk Factors, Nutrition.
Michal Hershfinkel
 
zinc homeostasis, mediated by zinc sensing receptors and transporters. My research group is particularly interested in: 1) zinc brain homeostasis, as this ion has an important role during normal activity, yet it is highly toxic to neuronal cells. 2) Mechanisms linking zinc to cell growth and proliferation with particular emphasis on the role of zinc in wound healing. Key words describing my research would be: Zinc homeostasis, zinc sensing receptor, zinc signaling in the brain, zinc transport, zinc in wound healing.
Daniel Kafka
 
Antileukemic effects of drugs on myeloid leukemia cells Bone marrow morphology in human and mouse samples
Tehila Kaisman
Eitan Kugler
Yitzhak Lander
Tom Leibson
Dina Liebeschutz
Varda Litan
LITAL MARGALITH
Carmi Margolis
 
Clinical algorithms; Clinical instruction design.
Yafa Mizrachi-Nebenzahl
 
1. To find the most efficacious vaccination regime based on these 8 proteins, by altering the number of immunizations, site of immunization or adjuvant type in the mouse intranasal inoculation model system. 2. To identify protein fragments from the selected proteins that retain their protective immunogenicity in the mouse challenge model, but which do not display any linear sequence homology to human proteins. 3. To screen for the presence of antibodies against these fragments in the sera of infants and young Jewish and Bedouin populations in Israel. 4. To optimize the protective immunity by examining and comparing immunity conferred by different combinations of fragments and to explore the possibility of ligating the fragments to form a single polypeptide chain. 5. To prepare human vaccine-quality proteins (GMP). 6. Pre-IND application to the FDA. the differences between immune responses in S. pneumoniae carriage and in S. pneumoniae disease are as yet unclear. To understand better how an appropriate protective immune response is developed will require insight into the relative contribution of innate and adaptive immune responses, and characterization of S. pneumoniae virulence factors plus their cognate host receptors. Such advances are critical to the development of future therapeutic or preventive interventions.
Amir Mor
Igor Morozov
Asher moshe Moser
Michael Moshe
Michael Nash
Hilli Nativ
Mir Pillar
Ruth Rafaeli
Lior Reichal
Liz Ronen
Simcha Rubens
Ofer Sachs
Iftach Sagy
Shimrit Elana Shabat
Nataly Sharon
Nufar Sharon
Lionel Slonovik
Sheli Snir
Zvi Steinberger
Sheila Washavsky
Dahlia Weizman
Adi Yanai
Amanda Yiftah-El
Anat Zer